Home  /   Products  /   Hepatotropic, choleretic  /   Phospholipides, sodium glycyrrhizate (Phosphogliv) – [50 capsules]

Phospholipides, sodium glycyrrhizate (Phosphogliv) – [50 capsules]


Hepatoprotective agent

Phosphogliv capsules is a combined remedy that has a membrane-stabilizing, hepatoprotective and antiviral effect. It is used for fatty liver degeneration.

SKU: 63190 Category:



active ingredients : phospholipids, sodium glycyrrhizinate;

1 capsule contains phospholipids in terms of 100% substance 65 mg, sodium glycyrrhizinate 35 mg;

excipients: microcrystalline cellulose, calcium carbonate, calcium stearate, talc, colloidal silicon dioxide.

the capsule shell contains: titanium dioxide (E 171), iron oxide black (E172), sunset yellow dye (E 110), gelatin.

Phosphogliv Pharmacodynamics

Combined remedy. It has a membrane-stabilizing, hepatoprotective and antiviral effect.

Phosphatidylcholine (the main component of phospholipids) is the main structural element of cellular and intracellular membranes, capable of restoring their structure and functions in case of damage, showing a cytoprotective effect. It normalizes protein and lipid metabolism, prevents the loss of hepatocidama enzymes and other active substances, restores the detoxification function of the liver, inhibits the formation of connective tissue, reducing the risk of liver fibrosis and cirrhosis.

Glycyrrhizic acid has an anti-inflammatory effect, inhibits the reproduction of viruses in the liver and other organs by stimulating the production of interferons, increasing phagocytosis, and increasing the activity of natural killer cells. It has a hepatoprotective effect due to antioxidant and membrane stabilizing activity. Potentiates the action of endogenous corticosteroids, has anti-inflammatory and anti-allergic effects in non-infectious liver lesions.

With skin lesions, due to the membrane-stabilizing and anti-inflammatory action of the components, it limits the spread of the process and contributes to the regression of the disease.



– Fatty liver degeneration (hepatosis);
– Alcoholic, toxic, including drug-induced liver damage;
– In the treatment of viral hepatitis, cirrhosis and psoriasis.
Contraindications .
– Hypersensitivity to glycyrrhizic acid, phosphatidylcholine or other components of Phosphogliv;
– Antiphospholipid syndrome;
– Pregnancy (data on efficacy and safety are insufficient);
– Breast-feeding (data on efficacy and safety are insufficient);
– Childhood under 12 years of age (data about efficacy and safety are insufficient).
Dosage and administration
  • Taken orally, with a meal, without chewing, with plenty of liquids.
  • The recommended dosage regimen for adults and children over 12 years – 2 capsules 3 times a day.
  • Duration of use may be up to 6 months, on average 3 months.